Washington University begins recruiting for phase 3 of Covid-19 vaccine trial

Washington University begins recruiting for phase 3 of Covid-19 vaccine trial

bizjournals

Published

The Washington University School of Medicine is a testing site for the Janssen Pharmaceutical Cos. of Johnson & Johnson’s phase 3 clinical research study. The study, called the ENSEMBLE trial, evaluates the safety and efficacy of Janssen’s investigational Covid-19 vaccine candidate JNJ-78436735, also known as Ad26.COV2.S. The phase 3 randomized, double-blind and placebo-controlled clinical trial is designed to evaluate the safety and efficacy of a single dose of the vaccine candidate versus…

Full Article